The clinical significance of soluble E-cadherin in nonsmall cell lung cancer

• Published in: Experimental Oncology
• Date: 2006
• Main Authors: Charalabopoulos, K., Gogali, A., Dalavaga, Y., Daskalopoulos, G., Vassiliou, M., Bablekos, G., Karakosta, A., Constantopoulos, S.
• Format: Article
• Language: English
• Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2006
• Subjects: Short communications
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/137548
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: The clinical significance of soluble E-cadherin in nonsmall cell lung cancer / 
 K. Charalabopoulos, A. Gogali, Y. Dalavaga, G. Daskalopoulos, M. Vassiliou, G. Bablekos, 
 A. Karakosta, S. Constantopoulos // Experimental Oncology. — 2006. — Т. 28, № 1. — С. 83-85. — Бібліогр.: 24 назв. — англ.

Aim: Aberrant expression of the epithelial transmembrane adhesion molecule E-cadherin (E-cad) has been associated with many human malignancies. In the present study the clinical significance of serum levels of soluble E-cadherin (sE-cad) in newly diagnosed patients with non small cell lung cancer (N...